Regulation of alternative splicing of Bcl-x by BC200 contributes to breast cancer pathogenesis.
about
Insights from Global Analyses of Long Noncoding RNAs in Breast CancerIdentifying the cellular location of brain cytoplasmic 200 RNA using an RNA-recognizing antibody.LINC00978 predicts poor prognosis in breast cancer patients.Long Noncoding RNAs in Cancer and Therapeutic Potential.Biosynthesis of brain cytoplasmic 200 RNA.Prognostic significance of long noncoding RNA Z38 as a candidate biomarker in breast cancer.LncRNA-mediated regulation of cell signaling in cancer.The long non-coding RNA BC200 (BCYRN1) is critical for cancer cell survival and proliferation.Long non-coding RNA00544 serves as a potential novel predictive and prognostic marker for HR+ HER2- subtype breast cancer.Role of the CRISPR system in controlling gene transcription and monitoring cell fate (Review).Post-Transcriptional Regulation of Anti-Apoptotic BCL2 Family Members.Regulation of BC200 RNA-mediated translation inhibition by hnRNP E1 and E2.Upregulation of LncRNA BCYRN1 promotes tumor progression and enhances EpCAM expression in gastric carcinoma.New insights into long noncoding RNAs and their roles in glioma.Brain cytoplasmic RNA 1 suppresses smooth muscle differentiation and vascular development in mice.Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics.Deciphering the roles of lncRNAs in breast development and disease.TRAF4-mediated ubiquitination of NGF receptor TrkA regulates prostate cancer metastasis.CRISPR therapeutic tools for complex genetic disorders and cancer (Review).
P2860
Q33787422-704BCCEE-3362-4BF8-A8F6-400AF2596905Q33874495-A585D165-C581-4B10-8DD1-11DFD452159AQ37448978-4161B3BB-C2B4-48C2-A085-010A12B2DD49Q38641303-102E6B0B-4FD7-4220-80F5-DDF9B9B5AC4AQ38650693-7C85DEF7-DB20-49E5-897C-AF5F07DC07E9Q38936118-9AF23E74-EB0E-4530-935B-56A4E85D0B99Q39366670-51E26289-9721-4A3D-8388-4CF955D489BDQ41047103-4F1661C5-8AEF-4E85-8961-68CDDE2212B1Q42078197-D91B34D6-8091-4E50-B1FB-89D753094516Q47235195-B0ACAD33-3104-44BE-B041-AE1B510DE18AQ47716556-B55C6293-251B-4FE6-916F-339E43E9622BQ48380597-A1481711-1DAC-47DC-9D37-26897146335DQ49536537-7E714F23-E238-44FD-99FE-6EADB5530D53Q49843574-00A69511-A1E8-476C-983A-0B6448FAF883Q51738946-69DEDE99-8BE3-4D6B-95FA-A2FBA1483A06Q52564290-8F5706CC-D50A-4D8D-9BAE-FD87010746ABQ54975879-80F49CC4-59C3-46ED-9543-3F2BA458871DQ54979954-6F1D528B-6C55-497B-9C4C-14CD38E3F9C9Q55383943-085108B2-8B54-45A9-9FEB-55F569194EC1
P2860
Regulation of alternative splicing of Bcl-x by BC200 contributes to breast cancer pathogenesis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Regulation of alternative spli ...... to breast cancer pathogenesis.
@en
Regulation of alternative spli ...... to breast cancer pathogenesis.
@nl
type
label
Regulation of alternative spli ...... to breast cancer pathogenesis.
@en
Regulation of alternative spli ...... to breast cancer pathogenesis.
@nl
prefLabel
Regulation of alternative spli ...... to breast cancer pathogenesis.
@en
Regulation of alternative spli ...... to breast cancer pathogenesis.
@nl
P2093
P2860
P356
P1476
Regulation of alternative spli ...... to breast cancer pathogenesis.
@en
P2093
R Pochampally
P2860
P356
10.1038/CDDIS.2016.168
P50
P577
2016-06-09T00:00:00Z